Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Intraoperative Dexmedetomidine Use, MMP-8, and Postoperative Delirium After Cardiac Surgery With Cardiopulmonary Bypass

A legfontosabb adatok

Ki végzi
Shusheng Li
Hol
Kína1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Résztvevők
5688 fő vett részt
Kezdés
2023. ápr. 1.
Befejezés
2024. okt. 15.
A vizsgálat típusa
Megfigyeléses, 4 csoport
A vizsgált kezelések
  • Dexmedetomidine
A regiszteradat frissítve
2026. szeptember 9.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 9 feltétel megnézéseKevesebb

Ki vehet részt

  • Adults aged 18 years or older
  • Patients undergoing cardiac surgery with cardiopulmonary bypass (CPB)
  • For the retrospective cohort, eligible patients undergoing cardiac surgery with CPB at the three participating campuses of Tongji Hospital between January 2015 and December 2022
  • For the prospective biomarker cohort, eligible participants enrolled between April 2023 and September 2024 with archived plasma samples collected preoperatively, at the end of surgery, and 24 h postoperatively, together with linked clinical data

Ki nem vehet részt

  • Emergency surgery
  • Conditions precluding dexmedetomidine use, including second- or third-degree atrioventricular block without a pacemaker, uncontrolled hypotension, acute cerebrovascular disease, or known hypersensitivity to dexmedetomidine
  • Severe neurological or psychiatric disorders, including a history of treatment for severe mental illness
  • Inability to communicate effectively because of severe hearing, visual, or speech impairments
  • Pregnancy or breastfeeding

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

This observational study evaluated the association between intraoperative dexmedetomidine use and postoperative delirium (POD) in adults undergoing cardiac surgery with cardiopulmonary bypass (CPB). The study included two linked clinical components. First, routinely collected clinical data from patients undergoing cardiac surgery with CPB at three campuses of Tongji Hospital between January 2015 and December 2022 were analyzed to evaluate the dexmedetomidine-POD association. Second, perioperative plasma samples and clinical data from a prospective observational cohort enrolled between April 2023 and September 2024 were used to characterize perioperative matrix metalloproteinase-8 (MMP-8) dynamics and their associations with intraoperative dexmedetomidine use and POD. Dexmedetomidine administration was determined by the attending anesthesiologist according to clinical judgment and routine anesthetic practice and was not assigned by the study protocol.

A vizsgálat 4 csoportja

  • Retrospective Cohort - Dexmedetomidine Exposed

    Patients in the retrospective multicampus cohort who underwent cardiac surgery with cardiopulmonary bypass between January 2015 and December 2022 and received intraoperative dexmedetomidine by continuous intravenous infusion as part of routine anesthetic care. Dexmedetomidine administration was determined by the attending anesthesiologist according to clinical judgment and was not assigned by the study protocol.

    Kezelés: Dexmedetomidine

  • Retrospective Cohort - No Dexmedetomidine Exposure

    Patients in the retrospective multicampus cohort who underwent cardiac surgery with cardiopulmonary bypass between January 2015 and December 2022 and did not receive intraoperative dexmedetomidine.

  • Prospective Cohort - Dexmedetomidine Exposed

    Participants in the previously established prospective observational cohort who underwent cardiac surgery with cardiopulmonary bypass between April 2023 and September 2024 and received intraoperative dexmedetomidine as part of routine anesthetic care. Dexmedetomidine use was determined by the treating anesthesiologist and was not influenced by the study investigators. Archived perioperative plasma samples from these participants were used for the present MMP-8 analyses.

    Kezelés: Dexmedetomidine

  • Prospective Cohort - No Dexmedetomidine Exposure

    Participants in the previously established prospective observational cohort who underwent cardiac surgery with cardiopulmonary bypass between April 2023 and September 2024 and did not receive intraoperative dexmedetomidine. Archived perioperative plasma samples from these participants were used for the present MMP-8 analyses.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Association of Intraoperative Dexmedetomidine Use and Perioperative Plasma MMP-8 Dynamics With Postoperative Delirium in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
A regiszteradat frissítve
2026. szeptember 9.